Industry News

Sep 26, 2014
The Purple Book will list biologic and biosimilar products and will serve as a guide for interchangeability.
Sep 26, 2014
By BioPharm International Editors
Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.
Sep 25, 2014
By BioPharm International Editors
USP expresses its support for a consensus-based global approach to the naming of biologics.
Sep 25, 2014
By BioPharm International Editors
FDA report details risk mitigation projects.
Sep 25, 2014
By BioPharm International Editors
NIH continues funding for tissue chips to be used in the development of therapeutics.
Sep 23, 2014
By BioPharm International Editors
Regulations, product protection, and cost management are top concerns of supply chain decision makers.
Sep 19, 2014
By BioPharm International Editors
GS1 publishes a healthcare industry guideline describing how to implement GS1 standards to support requirements of the 2013 US Drug Supply Chain Security Act.
Sep 19, 2014
By BioPharm International Editors
PCI's acquisition of Biotech Services International expands the packaging services provider's presence in Europe.
Sep 18, 2014
By BioPharm International Editors
GPhA throws its support behind a bill to prohibit companies from using REMS practices to deter competition.
Sep 12, 2014
By BioPharm International Editors
European Commission granted the first biosimilar insulin to receive regulatory approval in Europe.
native1_300x100
lorem ipsum